Search results for: Innovation Policy Prize
Filter search results
Hospital Purchasing
1 September 1972
Out of £868 minion spent on the revenue account of the hospital service in England and Wales in 1970, £242 million, or a little over one quarter, was spent on…
Forward Together: Complementarity of Public and Charitable Research with Respect to Private Research Spending
9 January 2009
The debate continues as to whether public/charitable research replaces private research that otherwise would have occurred, or stimulates additional private research, or does neither. Given the extent of public and…
Deliberative Processes in Decisions about Health Care Technologies
1 June 2009
In the UK and elsewhere, choices about how to allocate health care resources are guided not only by economic calculations, but also by social value judgments such as those relating…
The Impact of Health Technology Assessment on Drug Development
3 January 2009
Health technology assessment (HTA) has become a critical basis for pricing and reimbursement decision-making worldwide. In some countries, extensive requirements for data are set out in guidances or regulation and…
Brand Names in Prescribing
1 September 1976
To present a balanced view of the brand name/generic controversy and the associated field of bioavailability. Many have discussed these problems; scientists, politicians, industrialists, legislators, hospital pharmacists, physicians, and clinical…
Tsvetelina Mueller
21 August 2024
…business transformation, Lina has lived and worked in 11 diverse countries, bringing a unique perspective to her work. As a catalyst for progress, she is passionate about healthcare innovation and…
Adverse Reactions and the Community
1 November 1982
Conference of Scottish Pharmacists, Aviemore, 21 November 1982. The aim is to do two things. First, to put the experience with benoxaprofen into a broader and cooler perspective. Secondly, to…
Needs of the Pharmaceutical Manufacturers from Their Medical Departments in the 1980s
1 February 1983
This paper was originally written for the benefit of a single pharmaceutical company. However the company agreed when it was commissioned that it should be made generally available once it…
Issues in Development: a Guide
5 January 1983
Unlike the great majority of OHE publications, this paper was not researched and written ‘in-house’. It is a minimally edited translation of a study prepared in German by Dr Klaus…